{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910777423403321"]
[null,null,"Titolo",null,"International benchmarking of US immunology research / / Panel on International Benchmarking of US Immunology Research, Committee on Science, Engineering, and Public Policy, National Academy of Sciences, National Academy of Engineering, Institute of Medicine"]
[null,null,"Pubbl/distr/stampa",null,"Washington, DC, : National Academy Press, 1999"]
[null,null,"Descrizione fisica",null,"1 online resource (60 pages) : illustrations"]
[null,null,"Disciplina",null,"616.079072"]
[null,null,"Soggetti",null,"Immunology - Research"]
[{"$nulls":4},"Immunity"]
[{"$nulls":4},"Immunochemistry"]
[{"$nulls":4},"Immunogenetics"]
[{"$nulls":4},"Benchmarking (Management)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Prepublication copy.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH\"\"; \"\"Copyright\"\"; \"\"PREFACE\"\"; \"\"CONTENTS\"\"; \"\"EXECUTIVE SUMMARY\"\"; \"\"1 INTRODUCTION\"\"; \"\"1.1 HOW IMPORTANT IS IT FOR THE UNITED STATES TO LEAD IN IMMUNOLOGY RESEARCH?\"\"; \"\"1.2 WHAT IS IMMUNOLOGY?\"\"; \"\"1.3 IMMUNOLOGY AS AN ACADEMIC DISCIPLINE\"\"; \"\"1.4 WHAT IS THE INTERNATIONAL NATURE OF IMMUNOLOGY?\"\"; \"\"1.5 WHAT ARE SOME CAVEATS?\"\"; \"\"1.6 PANEL CHARGE AND RATIONALE\"\"; \"\"2 BENCHMARKING RESULTS\"\"; \"\"2.1 METHODS\"\"; \"\"2.1.1 Reputation Survey\"\"; \"\"2.1.2 Citation Analysis\"\"; \"\"2.1.3 Journal Publication Analysis\"\"; \"\"2.2 RESULTS\"\""]
[{"$nulls":4},"\"\"2.2.1 Reputation Survey\"\" \"\"2.2.2 Citation Analysis\"\"; \"\"2.2.3 Journal Publication Analysis\"\"; \"\"2.3 SUMMARY\"\"; \"\"3 KEY FACTORS\"\"; \"\"3.1 FUNDING\"\"; \"\"3.2 HUMAN RESOURCES\"\"; \"\"3.3 INFRASTRUCTURE\"\"; \"\"3.4 BIOTECHNOLOGY AND PHARMACEUTICAL FIRMS\"\"; \"\"3.5 THE CLINICAL TRIAL\"\"; \"\"4 LIKELY FUTURE POSITION\"\"; \"\"4.1 FUNDING AND RESOURCE LIMITATIONS\"\"; \"\"4.2 INCREASED COMPETITION FROM EUROPE AND OTHER COUNTRIES\"\"; \"\"4.3 CLINICAL IMMUNOLOGY AND THE SHIFT TOWARD HMOS\"\"; \"\"4.4 TRAINING OF US STUDENTS\"\"; \"\"5 SUMMARY AND CONCLUSIONS\"\""]
[{"$nulls":4},"\"\"5.1 THE UNITED STATES IS THE WORLD LEADER IN ALL THE MAJOR "]
[{"$nulls":4},"SUBFIELDS OF IMMUNOLOGY BUT IS ONLY AMONG THE WORLD LEADERS IN\"\"\"\"5.2 FLEXIBILITY TO PURSUE ORIGINAL AND INNOVATIVE RESEARCH IDEAS HAS ATTRACTED BOTH DOMESTIC AND INTERNATIONAL HUMAN\"\"; \"\"5.3 INDUSTRIAL INTERESTS HAVE FOSTERED MANY STRIKING BREAKTHROUGHS IN IMMUNOLOGY\"\"; \"\"5.4 A SCARCITY OF LARGE-SCALE CLINICAL TRIALS IN IMMUNOLOGY CAN BE ATTRIBUTED TO SHORTAGES OF FUNDING AND OF QUALIFIED\"\"; \"\"5.5 SHIFTING FEDERAL AND INDUSTRY PRIORITIES, A POTENTIAL REDUCTION IN ACCESS TO DOMESTIC AND FOREIGN TALENT, AND THE\"\"; \"\"REFERENCES\"\"\"\"APPENDIX PANEL AND STAFF BIOGRAPHICAL INFORMATION\"\"; \"\"STAFF\"\""]